Lipid-heparin infusion suppresses the IL-10 response to trauma in subcutaneous adipose tissue in humans

Obesity

Volumn 19, Issue 4, 2011, Pages 715-721

  Ikeoka, Dimas T ^a   Pachler, Christoph ^a   Mader, Julia K ^a   Bock, Gerlies ^a   Neves, Ana L ^a   Svehlikova, Eva ^a   Feichtner, Franz ^b   Koehler, Gerd ^a   Wrighton, Christopher J ^b   Pieber, Thomas R ^a,b   Ellmerer, Martin ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b JOANNEUM RESEARCH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTOKINE; FATTY ACID; GLUCOSE; HEPARIN; INSULIN; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; LIPID; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CYTOKINE PRODUCTION; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOMODULATION; IN VIVO STUDY; INFLAMMATION; INTERSTITIAL FLUID; NORMAL HUMAN; SUBCUTANEOUS FAT; TISSUE LEVEL;

ADIPOKINES; ADULT; BLOOD GLUCOSE; CATHETERS; CHEMOKINE CCL2; CROSS-OVER STUDIES; CYTOKINES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS, NONESTERIFIED; HEPARIN; HUMANS; INFLAMMATION; INSULIN; INTERLEUKIN-10; INTERLEUKIN-6; INTERLEUKIN-8; LIPIDS; MALE; OBESITY; RETROSPECTIVE STUDIES; SUBCUTANEOUS FAT; TRIGLYCERIDES; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 79953205178     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2010.227     Document Type: Article

References (35)

1. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001;60:349-356. (Pubitemid 32772450)
2. Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol 2007;27:2276-2283. (Pubitemid 350203940)
3. Mohamed-Ali V, Pinkney JH, Coppack SW. Adipose tissue as an endocrine and paracrine organ. Int J Obes Relat Metab Disord 1998;22:1145-1158. (Pubitemid 28548534)
4. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity J Am Soc Nephrol 2004;15:2792-2800. (Pubitemid 41103388)
5. Bastard JP, Maachi M, Lagathu C et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12
6. Bergman RN, Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrinol Metab 2000;11:351-356.
7. Boden G, She P Mozzoli M et al. Free fatty acids produce insulin resistance and activate the proinflammatory nuclear factor-?B pathway in rat liver Diabetes 2005;54:3458-3465 (Pubitemid 43334336)
8. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995;95:2409-2415.
9. Obunai K, Jani S, Dangas GD. Cardiovascular morbidity and mortality of the metabolic syndrome. Med Clin North Am 2007;91:1169-1184, x. (Pubitemid 350010914)
10. Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-1119. (Pubitemid 40629025)
11. Nguyen MT, Satoh H, Favelyukis S et al. JNK and tumor necrosis factor-α mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes. J Biol Chem 2005;280:35361-35371 (Pubitemid 41532725)
12. Hirosumi J, Tuncman G, Chang L et al. A central role for JNK in obesity and insulin resistance. Nature 2002;420:333-336. (Pubitemid 35398190)
13. Karin M, Yamamoto Y, Wang QM. The IKK NF-?B system: a treasure trove for drug development. Nat Rev Drug Discov 2004;3:17-26. (Pubitemid 38088695)
14. Bradley RL, Fisher FF, Maratos-Flier E. Dietary fatty acids differentially regulate production of TNF-α and IL-10 by murine 3T3-L1 adipocytes. Obesity (Silver Spring) 2008;16:938-944. (Pubitemid 351620481)
15. Pachler C, Ikeoka D, Plank J et al. Subcutaneous adipose tissue exerts proinflammatory cytokines after minimal trauma in humans. Am J Physiol Endocrinol Metab 2007;293:E690-E696. (Pubitemid 47358980)
16. Ellmerer M, Schaupp L, Brunner GA et al. Measurement of interstitial albumin in human skeletal muscle and adipose tissue by open-flow microperfusion. Am J Physiol Endocrinol Metab 2000;278:E352-E356. (Pubitemid 30131183)
17. Bodenlenz M, Schaupp LA, Druml T et al. Measurement of interstitial insulin in human adipose and muscle tissue under moderate hyperinsulinemia by means of direct interstitial access. Am J Physiol Endocrinol Metab 2005;289:E296-E300. (Pubitemid 41076631)
18. Weinhandl H, Pachler C, Mader JK et al. Physiological hyperinsulinemia has no detectable effect on access of macromolecules to insulin-sensitive tissues in healthy humans. Diabetes 2007;56:2213-2217 (Pubitemid 47358227)
19. Orban Z, Remaley AT Sampson M, Trajanoski Z, Chrousos GP. The differential effect of food intake and ß-adrenergic stimulation on adipose-derived hormones and cytokines in man. J Clin Endocrinol Metab 1999;84:2126-2133 (Pubitemid 30647044)
20. Murdolo G, Herder C, Wang Z et al. In situ profiling of adipokines in subcutaneous microdialysates from lean and obese individuals. Am J Physiol Endocrinol Metab 2008;295:E1095-E1105
21. Cassatella MA, Meda L, Bonora S, Ceska M, Constantin G. Interleukin 10 (IL-10) inhibits the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-1 ßin mediating the production of IL-8 triggered by lipopolysaccharide. J Exp Med 1993;178:2207-2211 (Pubitemid 23344879)
22. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
23. Straczkowski M, Kowalska I, Nikolajuk A, Krukowska A, Gorska M. Plasma interleukin-10 concentration is positively related to insulin sensitivity in young healthy individuals. Diabetes Care 2005;28:2036-2037. (Pubitemid 41060983)
24. Horton TJ, Hill JO. Prolonged fasting significantly changes nutrient oxidation and glucose tolerance after a normal mixed meal. J Appl Physiol 2001;90:155-163 (Pubitemid 32038516)
25. Salgin B, Marcovecchio ML, Humphreys SM et al. Effects of prolonged fasting and sustained lipolysis on insulin secretion and insulin sensitivity in normal subjects. Am J Physiol Endocrinol Metab 2009;296: E454-E461
26. Greenfield M, Kolterman O, Olefsky J, Reaven GM. Mechanism of hypertriglyceridaemia in diabetic patients with fasting hyperglycaemia. Diabetologia 1980;18:441-446 (Pubitemid 10114466)
27. Belfort R, Mandarino L, Kashyap S et al. Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 2005;54:1640-1648. (Pubitemid 40770753)
28. Adiels M, Olofsson SO, Taskinen MR, Borén J. Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome. Arterioscler Thromb Vasc Biol 2008;28:1225-1236.
29. Ginsberg HN, Zhang YL, Hernandez-Ono A. Regulation of plasma triglycerides in insulin resistance and diabetes. Arch Med Res 2005;36: 232-240. (Pubitemid 40755136)
30. Dandona P Chaudhuri A, Mohanty P Ghanim H. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007;10:511-517
31. Feghali CA, Wright TM. Cytokines in acute and chronic inflammation Front Biosci 1997;2:d12-d26.
32. Fontana L, Eagon JC, Trujillo ME, Scherer PE, Klein S. Visceral fat adipokine secretion is associated with systemic inflammation in obese humans. Diabetes 2007; 56: 1010-1013 (Pubitemid 46525079)
33. Shimomura I, Funahashi T, Takahashi M et al. Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity Nat Med 1996;2:800-803. (Pubitemid 26225097)
34. Wellen KE, Hotamisligil GS. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-1788. (Pubitemid 38063699)
35. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006;2: 367-373 (Pubitemid 44734225)